Fluvastatin
Side effects
Options:
Show MedDRA Preferred Terms
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
Gastrointestinal disorder
|
6.3%
|
4.5%
|
x
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Angiopathy
|
5.8%
|
4.2%
|
x
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Influenza-like symptoms
|
5.1% - 7.1%
|
5.7%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Blood creatine phosphokinase increased
|
common
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
Trauma
|
4.2% - 5.1%
|
4.8%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Rhinitis
|
1.5% - 4.9%
|
|
x
|
x
|
|
|
|
|
|
x
|
x
|
|
|
|
|
Headache
|
common, 0.9% - 8.9%
|
3% - 7.8%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Nervous system disorder
|
3.9%
|
3.5%
|
x
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Pharyngitis
|
2.4% - 3.8%
|
|
x
|
x
|
|
|
|
|
|
x
|
x
|
|
|
|
|
Abdominal pain
|
common, 0.7% - 4.9%
|
2% - 3.8%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Dyspepsia
|
common, 0.3% - 7.9%
|
2.3% - 3.2%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Arthropathy
|
3.2%
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Sinusitis
|
1.9% - 3.5%
|
1.9%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Constipation
|
0.8% - 3.3%
|
2.5%
|
x
|
x
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Cough
|
1.9% - 2.9%
|
|
x
|
x
|
|
|
|
|
|
x
|
x
|
|
|
|
|
Infection
|
2.3%
|
2%
|
x
|
x
|
|
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
x
|
Infestation NOS
|
2.3%
|
2%
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Urinary tract infection
|
1.6% - 2.7%
|
1.1%
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Connective tissue disorder
|
2.1%
|
1.8%
|
x
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Nausea
|
common, 0.4% - 3.2%
|
1.4% - 2%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Flatulence
|
0.8% - 2.6%
|
2.2% - 2.5%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Bronchitis
|
1% - 2.6%
|
1%
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Tooth disorder
|
1.4% - 2.1%
|
|
x
|
x
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Myalgia
|
postmarketing — 1.5% - 5%
|
2.3% - 4.5%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Diarrhoea
|
0.2% - 4.9%
|
2.1% - 4.2%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Fatigue
|
0.2% - 2.7%
|
1.8% - 2.3%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Upper respiratory tract infection
|
0.2% - 16.5%
|
1.9%
|
x
|
x
|
|
|
|
|
|
x
|
|
|
|
|
|
Abnormal vision
|
0% - 1.1%
|
1.4%
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Back pain
|
0.4% - 1.1%
|
1.6%
|
x
|
x
|
|
|
|
|
|
x
|
x
|
|
|
|
|
Arthritis
|
postmarketing, 1.3% - 2.1%
|
2%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Eructation
|
0% - 1.4%
|
1.1%
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Dizziness
|
postmarketing, 0.5% - 2.5%
|
1.8% - 2.5%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Chest pain
|
0.2% - 1.4%
|
0.5%
|
|
x
|
|
|
|
|
|
|
|
|
|
x
|
x
|
Abdominal pain upper
|
0.3%
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Insomnia
|
postmarketing — 0.2% - 2.7%
|
0.9% - 1.4%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Rash
|
postmarketing — 0.2% - 1.9%
|
1.6%
|
x
|
x
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Alopecia
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Amnesia
|
postmarketing
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Anaphylactic shock
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Haemolytic anaemia
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Angioedema
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Anorexia
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Anxiety
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Arthralgia
|
postmarketing, 0.2% - 4.1%
|
1.5%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Asthenia
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Confusional state
|
postmarketing
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Dermatitis
|
postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Dysgeusia
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Dyspnoea
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Eczema
|
postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Eosinophilia
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Toxic epidermal necrolysis
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Erythema multiforme
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Body temperature increased
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Flushing
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Gynaecomastia
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Hepatitis
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Hypersensitivity
|
postmarketing — 1% - 2.3%
|
2.2%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Hypoaesthesia
|
very rare, postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Jaundice cholestatic
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Leukopenia
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Cramp muscle
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Myopathy
|
postmarketing, rare
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Myositis
|
very rare, postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Nodule
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Ophthalmoplegia
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Pancreatitis
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Paraesthesia
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Neuropathy peripheral
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Polymyalgia rheumatica
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Pruritus
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Purpura
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Rhabdomyolysis
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Muscle spasms
|
postmarketing
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Stevens-Johnson syndrome
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Thrombocytopenia
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Tremor
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Urticaria
|
postmarketing, rare
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Vasculitis
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Vertigo
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Vomiting
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Chills
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Hepatic failure
|
postmarketing
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Dermatitis bullous
|
postmarketing
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Cataract
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Antinuclear antibody positive
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Muscular weakness
|
postmarketing, rare
|
|
x
|
x
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Hepatic necrosis
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Photosensitivity reaction
|
postmarketing
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Malaise
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Memory impairment
|
postmarketing
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Erectile dysfunction
|
postmarketing
|
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Cognitive impairment
|
postmarketing
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Dysaesthesia
|
very rare, postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Lupus erythematosus
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Facial paresis
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Transaminases increased
|
postmarketing, common
|
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Hepatitis chronic active
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Forgetfulness
|
postmarketing
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Hypersensitive syndrome
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Memory loss
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Peripheral nerve palsy
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Lenticular opacities
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Hepatocellular carcinoma
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Loss of libido
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Immune-mediated necrotising myopathy
|
postmarketing
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
x
|
Pancreatitis acute
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Arrhythmia
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
Atrial fibrillation
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Mental disorder
|
|
1.4%
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
|
|
|
|
Breast disorder
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
Conjunctivitis
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Gastritis
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Cardiac disorder
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Heartburn
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Hypertension
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Immune system disorder
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
Influenza
|
|
|
x
|
x
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
Intermittent claudication
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Renal failure acute
|
|
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Leg pain
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Myoglobinuria
|
|
|
x
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Nasopharyngitis
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Pain
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Pain in extremity
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Gastric disorder
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Sweating
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Syncope
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Erythema
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Oedema peripheral
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Unspecified disorder of skin and subcutaneous tissue
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
Dyspnoea exertional
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Tenderness
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Hepatobiliary disease
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
Muscle swelling
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
Photosensitivity
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
|
|
|
|
Gastrointestinal symptom NOS
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
Face oedema
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Hot flush
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Blood and lymphatic system disorders
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 62 |
Source: | medicines.org.au |
---|
Side effects: | 81 |
Source: | Health Canada |
---|
Side effects: | 74 |
Source: | FDA |
---|
Side effects: | 74 |
Source: | FDA |
---|
Side effects: | 76 |
Source: | FDA |
---|
Side effects: | 76 |
Source: | FDA Structured Product Label |
---|
Side effects: | 76 |
Source: | FDA |
---|
Side effects: | 82 |
Source: | FDA |
---|
Side effects: | 82 |
Source: | FDA |
---|
Side effects: | 109 |
Source: | FDA Structured Product Label |
---|
Side effects: | 109 |
Source: | FDA Structured Product Label |
---|
Side effects: | 109 |
Source: | FDA Structured Product Label |
---|
Side effects: | 110 |
Source: | FDA Structured Product Label |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|